z-logo
open-access-imgOpen Access
IMPLICATIONS OF CYP2D6 POLYMORPHISMS FOR THERAPEUTIC DRUG MONITORING IN PATIENTS WITH HYPERTENSION
Author(s) -
Lene Vernås Halvorsen,
Stine Gognstad,
Camilla Lund Søraas,
Camilla Ågnes,
Ulla Hjørnholm,
Vibeke Norheim Kjær,
Anja Camilla Svarstad,
Ola Undrum Bergland,
Karl Marius Brobak,
Arleen Aune,
Eirik Olsen,
Marit Dahl Solbu,
Eva Gerdts,
Rune Mo,
Fadl Elmula M. Fadl Elmula,
Morten Rostrup,
Sverre E. Kjeldsen,
Silja Skogstad Tuv,
Aud Høieggen,
Anne Cecilie K. Larstorp,
Mimi Stokke Opdal
Publication year - 2022
Publication title -
journal of hypertension
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.249
H-Index - 172
eISSN - 1473-5598
pISSN - 0263-6352
DOI - 10.1097/01.hjh.0000838764.61491.a8
Subject(s) - cyp2d6 , medicine , pharmacology , drug , pharmacogenetics , pharmacokinetics , therapeutic drug monitoring , population , genotype , metabolism , biology , genetics , cytochrome p450 , gene , environmental health

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here